Simpler Grants.gov #TI-26-006

Grant for Training and Distribution of Opioid Overdose Reversal Medications

This opportunity from the Substance Abuse and Mental Health Services Administration (SAMHSA) provides grant funding to support training and distribution of opioid overdose reversal medications: - Government Buyer: - Substance Abuse and Mental Health Services Administration (SAMHSA), a US federal agency - Program Details: - Grant under the First Responders-Comprehensive Addiction and Recovery Act (FR-CARA) program - Focused on training first responders and communities - Supports administration and distribution of FDA-approved opioid overdose reversal medications - Eligibility: - Open to states, local governmental entities, and American Indian/Alaska Native tribes and tribal organizations - Funding: - Total available funding: $35,600,000 - Expected number of awards: 118 - No cost sharing or matching required - Products/Services: - No specific OEMs, vendors, products, part numbers, or quantities specified - Emphasis on FDA-approved opioid overdose reversal medications (e.g., naloxone) - Notable Requirements: - Training and distribution must focus on FDA-approved medications - No administrative or procedural requirements highlighted

Description

The FR-CARA program aims to train first responders and communities in administering and distributing FDA-approved opioid overdose reversal medications. The program is statutorily limited to states, local governmental entities, and American Indian/Alaska Native tribes and tribal organizations. The funding opportunity number is TI-26-006, and the funding instrument type is a grant. The total funding amount is $35,600,000 with an expected 118 awards.

View original listing